BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Stock buybacks
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$116,000FY2021
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $116,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice